Today on Outsourcing-Pharma.com   GSK to strip down through outsourcing and offshoring Ranbaxys statin a drag on PPD's bottom line Major Singapore investment for Novartis Singapore's output down Contract manufacturing news in brief

Related Industry News   Wellcome boost for Alzheimer's research GSK axe begins to fall Cholesterol-releasing enzyme to reduce heart disease? Wockhardt makes latest US move

Breaking News on Outsourcing Pharma
Daily  Monday 29 October 2007		Forward to a colleague

	Technical / White Paper Benefits of integrating human tissue research in drug discovery The benefits of integrating human tissue research into drug discovery and development programs are in the confidence that they provide in the selection of the NCEs most likely to succeed in the clinic, and doing this in the most financially efficient way... Click Here Access Full Stories GSK to strip down through outsourcing and offshoring GlaxoSmithKline (GSK) is planning to strip itself down closer to the bare bones of the business through further outsourcing and offshoring, with hopes of making itself into a lean, mean, pharma machine... Read Ranbaxys statin a drag on PPD's bottom line PPD's decision to in-license an investigational compound is proving to be a drag on its bottom line as the firm continues to seek a development partner for the drug... Read Major Singapore investment for Novartis Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low... Read Singapore's output down Figures released today reveal a slow-down in Singapore's pharmaceutical manufacturing output compared to this time last year... Read Contract manufacturing news in brief Novavax, Cobra Biomanufacturing, Catalent Pharma Solutions, and Suven Life Sciences have all recently announced new contract manufacturing news... Read
	All News Headlines for: October | September | August
	Related Industry News Wellcome boost for Alzheimer's research The UK's largest charity, the Wellcome Trust, has awarded £1.3m (€1.9m) to fund the world's largest ever genome-wide association study to identify the genetic origins of Alzheimer's disease... Read GSK axe begins to fall GlaxoSmithKline (GSK) has been swift in implementing its plant cuts, already announcing the first sites to be axed mere hours after revealing its restructuring plans... Read Cholesterol-releasing enzyme to reduce heart disease? US researchers have identified an enzyme that reduces the build up of heart-disease causing plaques by removing the cholesterol that causes them to form... Read Wockhardt makes latest US move Indian generics specialist Wockhardt is continuing its drive to strengthen its foothold in the US market, snapping up US firm Morton Grove Pharmaceuticals... Read Weekly Comment Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release. Read Previous Headlines Almac to take on US with $100m Contract manufacturer Almac has set its sights on establishing a new US headquarters and has set aside $100m (€70m) for the purpose... Read GSK cut down by Avandia scare GlaxoSmithKline (GSK) has emerged as the latest pharma firm to announce closures and job cuts along with its third quarter results, yet another casualty of generic competition and product safety scares... Read Sanofi slammed by FDA over failure to act on Ketek fraud The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm... Read Sigma-Aldrich set to break $2bn yearly sales barrier Sigma-Aldrich continued its strong year with both revenues and pre-tax profits showing strong double-digit growth in the third quarter predicting it will break the $2bn (€1.4bn) revenue mark this year... Read MannKind all but shuts the door on Pfizer MannKind Corporation needs an outside boost to get its inhaled insulin off the ground, but the likelihood of that partner being Pfizer is a 'very long shot', the president of the company says... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com